COVID survivors may be at a greater risk of developing Parkinson’s–like symptoms, researchers warn. What to know to protect your health
[u]However grim the findings, the team’s study resulted in some positive news: ALS drug riluzole, drug metformin, and cancer drug imatinib appear to prevent the aforementioned type of neurons from becoming infected with COVID and, thus, losing their ability to function properly[/u]."
[u]However grim the findings, the team’s study resulted in some positive news: ALS drug riluzole, drug metformin, and cancer drug imatinib appear to prevent the aforementioned type of neurons from becoming infected with COVID and, thus, losing their ability to function properly[/u]."